Intervention by Pharmacist in Outpatient Service for Lenvatinib Therapy for Hepatocellular Carcinoma at Our Hospital and Its Usefulness
-
Published:2020-06-10
Issue:6
Volume:46
Page:303-313
-
ISSN:1346-342X
-
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
-
language:en
-
Short-container-title:Jpn. J. Pharm. Health Care Sci.
Author:
Ono Hiroyuki1, Tatsuta Ryosuke1, Nakahara Ryosuke1, Tanaka Ryota1, Itoh Hiroki1
Affiliation:
1. Department of Pharmacy, University Hospital, School of Medicine, Oita University
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference12 articles.
1. 1）Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz H, Goldberg RM, Sargent DJ, Cihon F, Cupit L, Wagner A; CORRECT Study Group, Regrafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicenter, randomized, placebo-controlled, phase 3 trial, Lancet, 2013, 381, 303-312． 2. 2）Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M, S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase Ⅲ trial, Lancet Oncol, 2008, 9, 215-221． 3. 3）土谷順彦, 羽渕友則, 固形腫瘍における分子標的薬の現状と課題, Drug Delivery System, 2010, 25, 134-142． 4. 4）Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A, Park JW, Han G, Jassem J, Blanc JF, Vogel A, Komov D, Evans TRJ, Lopez C, Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T, Ren M, Cheng AL, Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial, Lancet, 2018, 391, 1163-1173． 5. 5）Cho JY, Paik YH, Lim HY, Kim YG, Lim HK, Min YW, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Clinical parameters predictive of outcomes in sorafenib treated patients with advanced hepatocellular carcinoma, Liver Int, 2013, 33, 6950-6957．
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Usefulness of Outpatient Pharmacist Interventions for Lenvatinib-treated Patients;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2021-11-10
|
|